EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein

Christopher L D McMillan, Danushka K Wijesundara, Jovin J Y Choo, Alberto A Amarilla, Naphak Modhiran, Germain J P Fernando, Alexander A Khromykh, Daniel Watterson, Paul R Young, David A Muller

Journal of General Virology · 2024

DOI: 10.1099/jgv.0.001947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2024. Verfasst von Christopher L D McMillan und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Innovation and Tourism Industry Development, Queensland Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has highlighted the need for vaccines capable of providing rapid and robust protection. One way to improve vaccine efficacy is delivery via microarray patches, such as the Vaxxas high-density microarray patch (HD-MAP). We have previously demonstrated that delivery of a SARS-CoV-2 protein vaccine candidate, HexaPro, via the HD-MAP induces potent humoral immune responses. Here, we investigate the cellular responses induced by HexaPro HD-MAP vaccination. We found that delivery via the HD-MAP induces a type one biassed cellular response of much greater magnitude as compared to standard intramuscular immunization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCOVID-19AnimalsMiceHumansPandemicsSARS-CoV-2VaccinationImmunity, CellularCOVID-19 VaccinesAntibodies, ViralImmunity, HumoralAntibodies, Neutralizing

Stichwörter der Autor:innen

SARS-CoV-2T cellscellular immunitymicroarray patchmicroneedlesmucosal immunityvaccine

Substanzen

spike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19 VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, Queensland 4072 and 4029, Australia.
  • Vaxxas Biomedical Facility, Hamilton, Queensland 4007, Australia.

Förderung

  • Department of Innovation and Tourism Industry Development, Queensland Government

Zitieren

APA

McMillan, C. L. D., Wijesundara, D. K., Choo, J. J. Y., Amarilla, A. A., Modhiran, N., Fernando, G. J. P., Khromykh, A. A., Watterson, D., Young, P. R., & Muller, D. A. (2024). Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein. Journal of General Virology. https://doi.org/10.1099/jgv.0.001947

Vancouver

McMillan CLD, Wijesundara DK, Choo JJY, Amarilla AA, Modhiran N, Fernando GJP, et al. Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein. Journal of General Virology. 2024. doi:10.1099/jgv.0.001947

BibTeX
@article{McMillan2024,
  author = {McMillan, Christopher L D and Wijesundara, Danushka K and Choo, Jovin J Y and Amarilla, Alberto A and Modhiran, Naphak and Fernando, Germain J P and Khromykh, Alexander A and Watterson, Daniel and Young, Paul R and Muller, David A},
  title = {Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein},
  journal = {Journal of General Virology},
  year = {2024},
  doi = {10.1099/jgv.0.001947}
}
Kostenlos starten →